Prescription Drug News and Research

RSS

Research shows link between higher generic drug use and Medicare Part D star ratings

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that Medicare Part D prescription plans with higher generic drug use have higher summary star ratings and improved member experience.

25 Oct 2018

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis, Inc. today announced results from two analyses evaluating the effect of PD-L1 expression or prior treatment with immune checkpoint inhibitors on the efficacy of cabozantinib in patients with advanced renal cell carcinoma (RCC). The findings are being presented this week at the European Society for Medical Oncology 2018 Congress being held October 19-23 in Munich, Germany.

22 Oct 2018

Many primary care doctors are still prescribing sedative drugs for older adults

Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

19 Oct 2018

Podcast: KHN’s ‘What the Health?’ Republicans’ preexisting political problem

Ensuring that people with preexisting health conditions can get and keep health insurance has become one of the leading issues around the country ahead of this fall's midterm elections.

18 Oct 2018

Medicare for all? CMS chief warns program has enough problems already

The Trump administration's top Medicare official Tuesday slammed the federal health program as riddled with problems that hinder care to beneficiaries, increase costs for taxpayers and escalate fraud and abuse.

16 Oct 2018

Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus

A new Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years.

16 Oct 2018

Trump administration, pharma exchange verbal volleys on drug-price transparency

The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.

16 Oct 2018

NHS tackles prescription fraud to save millions

The NHS has taken measures to stop patients from wrongfully claiming prescriptions for free. Prescription frauds, according to sources, cost the NHS £256 million annually. These measures would help reduce these costs by half.

15 Oct 2018

CU Denver professor receives funding to study opioid addiction treatment for chronic pain sufferers

The University of Colorado Denver and assistant psychology professor Dr. Amy Wachholtz were awarded more than $700,000 in funding by the National Institute of Health (NIH) to study treatments for chronic pain sufferers who become addicted to opioids. Recruitment is underway to enroll study patients for this clinical research.

12 Oct 2018

Careplus Health Plans achieves 5-star rating for the 2019 plan year

CarePlus Health Plans, Inc.'s Medicare Advantage plan in Florida achieved 5-stars - the highest possible rating - from the Centers for Medicare & Medicaid Services for the 2019 plan year.

11 Oct 2018

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

It took more than 10 minutes for paramedics to arrive after a housekeeper found a man collapsed on the floor of a bathroom in a Boston Veteran Affairs building.

3 Oct 2018

Podcast: KHN’s ‘What the Health?’ (Almost) Live from Austin!

President Donald Trump's proposed rule that would make it more difficult for immigrants to gain permanent status if they use government aid programs could have a major impact in Texas, with its large immigrant population.

28 Sep 2018

Workers overdose on the job, and employers struggle to respond

Jimmy Sullivan prepared for his job as a bricklayer the same way every morning for years: injecting a shot of heroin before leaving his car.

28 Sep 2018

Buried in Congress’ opioid bill is protection for personal drug imports

The final version of the massive opioid bill Congress released Wednesday would grant the Food and Drug Administration new powers to crack down on drug imports, but it also includes a provision — nearly killed in the Senate — to shield people who are just trying to buy cheaper, needed prescription medication from other countries.

27 Sep 2018

As states try to rein in drug spending, feds slap down one bold Medicaid move

States serve as “laboratories of democracy,” as U.S. Supreme Court Justice Louis Brandeis famously said. And states are also labs for health policy, launching all kinds of experiments lately to temper spending on pharmaceuticals.

21 Sep 2018

Ensysce receives award from NIDA to undertake development of opioid overdose protection platform

Ensysce Biosciences Inc. today announced receipt of Notice of Award from the National Institute on Drug Abuse, a four year award to undertake the pre-clinical and clinical development of the company's opioid overdose protection platform MPAR

17 Sep 2018

New Medicare Advantage tool to lower drug prices puts crimp in patients’ choices

Starting next year, Medicare Advantage plans will be able to add restrictions on expensive, injectable drugs administered by doctors to treat cancer, rheumatoid arthritis, macular degeneration and other serious diseases.

17 Sep 2018

Study: Poor older Americans most likely to rely on prescription opioids

Among older Americans, the poorest are the most likely to have used prescription opioids, according to a University at Buffalo study providing new insights into unexplored contours of the opioid crisis.

12 Sep 2018

Unwitting patients, copycat comments play hidden role in federal rule-making

A proposal to sharply cut a drug discount program that many hospitals rely on drew some 1,400 comments when the Trump administration announced its plan last year. Hundreds appeared to come from patients across the country — pleas from average Americans whose treatments for diseases such as cancer depend on costly medicines.

11 Sep 2018

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.

7 Sep 2018

Prescription Drug News and Research

Research shows link between higher generic drug use and Medicare Part D star ratings

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Many primary care doctors are still prescribing sedative drugs for older adults

Podcast: KHN’s ‘What the Health?’ Republicans’ preexisting political problem

Medicare for all? CMS chief warns program has enough problems already

Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus

Trump administration, pharma exchange verbal volleys on drug-price transparency

NHS tackles prescription fraud to save millions

CU Denver professor receives funding to study opioid addiction treatment for chronic pain sufferers

Careplus Health Plans achieves 5-star rating for the 2019 plan year

VA adding opioid antidote to defibrillator cabinets for quicker overdose response

Podcast: KHN’s ‘What the Health?’ (Almost) Live from Austin!

Workers overdose on the job, and employers struggle to respond

Buried in Congress’ opioid bill is protection for personal drug imports

As states try to rein in drug spending, feds slap down one bold Medicaid move

Ensysce receives award from NIDA to undertake development of opioid overdose protection platform

New Medicare Advantage tool to lower drug prices puts crimp in patients’ choices

Study: Poor older Americans most likely to rely on prescription opioids

Unwitting patients, copycat comments play hidden role in federal rule-making

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News